# Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

> **NCT05837104** · PHASE2 · RECRUITING · sponsor: **Mclean Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Bipolar I Disorder
- Depression, Anxiety
- Stress

## Interventions

- **DRUG:** Magnesium vitamin B6
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05837104
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-13
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05837104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05837104, "Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT05837104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*